Capital Flow Monitor · Sponsors · CIK 2112659
ILIAD BIOTECHNOLOGIES, INC.
4581 WESTON ROAD, WESTON, FL, 33331 · (800) 603-3525
Biotechnology · Corporation· inc. DELAWARE true 2026
Fit score
—
Offering
$115.5M
Sold
$115.5M
% sold
100.0%
Investors
36
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-02-20 | D ·current | 506(b) | $115.5M | $115.5M | 100.0% | 36 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Keith Rubin — Executive Officer / Director, Weston, FL
- Mario Barro — Director, Weston, FL
-
Avi Naider — Director, Weston, FL
1 other raise
- Treeline Biosciences, Inc. $200.1M of $250.0M · 80.0%
-
Eric Edidin — Director, Weston, FL
10 other raises
- BH3 Debt Opportunity Fund III-Offshore L.P. $0 of —
- BH3 Debt Opportunity Fund III L.P. $0 of —
- DOF II-Park Tower Co-Invest LLC $23.7M of $23.7M · 100.0%
- Illuminare Biotechnologies Inc $3.7M of $4.0M · 91.3%
- BH3 Harel Debt Opportunity Fund, LP $21.0M of $21.0M · 100.0%
- BH3 Heritage FV III Feeder L.P. $15.0M of $50.0M · 30.0%
- Endo Ventures Cecelia SPV, LLC $94K of $94K · 100.0%
- Endo IV Cecelia SPV, LLC $591K of $591K · 100.0%
- Endo G100 Cecelia SPV LLC $109K of $109K · 100.0%
- Cecelia Health Holdings, Inc. $16.1M of $19.1M · 84.3%
- William Steinkrauss — Executive Officer, Weston, FL
Placement agents
- Walter C. Greenblatt · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.